As previously announced, John Bean Technologies Corporation ("JBT") has initiated a voluntary takeover offer to acquire all issued and outstanding shares of Marel hf. ("Marel"). The takeover offer wil ...

Compare up to three stocks to (MAREL.IC) by adding the symbol or company name. Compare up to three stocks to (MAREL.IC) by adding the symbol or company name.

The FINEARTS-HF trial showed that in patients with symptomatic HF with preserved or mildly reduced LVEF, finerenone resulted in a lower composite rate of worsening HF events and CV death compared with ...

Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and ...

has granted an extension of the expiration of JBT’s voluntary takeover offer to acquire all issued and outstanding shares of Marel hf. (ICL: Marel). CHICAGO, August 08, 2024--JBT Corporation ...

announced that its shareholders voted to approve the issuance of shares of JBT common stock in connection with JBT’s pending combination with Marel hf., at the special meeting of shareholders held ...

Highlighted text has been updated as of August 30, 2024. The PARAGON-HF trial failed to show that sacubitril/valsartan reduced adverse events among patients with HFpEF. Patients with HFpEF were ...

CHICAGO - JBT Corporation (NYSE: JBT), a significant player in the food and beverage industry's technology solutions segment, has announced an extension of its voluntary takeover offer for all issued ...